Continuum Health Ventures

CardiaTec is a digital biotechnology company focused on revolutionizing cardiovascular drug discovery through the integration of artificial intelligence and specialized expertise. The company aims to transform the understanding of cardiovascular disease by developing AI-driven platforms for target identification and novel drug discovery. This approach seeks to provide effective therapeutics for cardiovascular diseases, addressing significant gaps in diagnostics, patient stratification, and treatment options for conditions such as coronary artery disease. By leveraging advanced technology and scientific knowledge, CardiaTec is dedicated to improving healthcare outcomes related to cardiovascular health.

Immunis is a private biotechnology company focused on addressing age and disease-related immune decline through innovative stem cell-derived therapies. The company specializes in utilizing human stem cells to create specific populations of cells that secrete therapeutic factors. This approach aims to enable healthcare professionals to enhance immune system development, modulation, and overall health in patients. By harnessing the potential of stem cell technology, Immunis seeks to offer novel treatment options that can improve immune function and combat the effects of aging and various diseases.

Developer of a secure collaboration platform designed to create secure data access to support impactful algorithm validation and development. The company's platform supports end-to-end data and algorithm encryption that ensures data security, it uses primary data from the source rather than synthetic or de-identified data, eliminates the risk of data exfiltration and interrogation of the algorithm IP from insiders and third parties, and acts as the middleman and matchmaker between data stewards and algorithm developers, helping healthcare organizations in keeping their data secure in their private cloud infrastructure.

Immunis is a private biotechnology company focused on addressing age and disease-related immune decline through innovative stem cell-derived therapies. The company specializes in utilizing human stem cells to create specific populations of cells that secrete therapeutic factors. This approach aims to enable healthcare professionals to enhance immune system development, modulation, and overall health in patients. By harnessing the potential of stem cell technology, Immunis seeks to offer novel treatment options that can improve immune function and combat the effects of aging and various diseases.

Enara Health is a healthcare technology company that has developed a platform focused on scaling obesity treatment through personalized weight loss programs. The company leverages a proprietary algorithm to assist medical care providers by utilizing key insights, including genetics, blood work, and comprehensive medical and weight history. This data-driven approach informs tailored recommendations for nutrition, exercise, and medication plans, thereby facilitating healthier lifestyle choices for customers. By offering personalized support from professionals such as doctors and dietitians, Enara Health aims to empower individuals to achieve sustainable weight loss and reduce the risk of obesity-related diseases.

Sanctuary AI, founded in January 2018 and based in Vancouver, Canada, is focused on developing synthetic humans, referred to as "synths." The company's mission is to create robots that are indistinguishable from humans in physical appearance, cognitive abilities, and emotional responses. In addition to advancing cutting-edge technology, Sanctuary AI is committed to addressing the ethical implications associated with the creation of human-like machines.